These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 19035207)
1. [Analysis of apoptosis-related gene expression in different serum level of insulin-like growth factor-1 in mice breast cancer tissue]. Tang HB; Ye ZR; Ren YP; Zhang S; Chen GQ; Wu YP Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1018-21. PubMed ID: 19035207 [TBL] [Abstract][Full Text] [Related]
2. [Different expression of liver-specific insulin-like growth factor I gene in breast cancer; expression with mice]. Tang HB; Ren YP; Hu Y; Zhu ZY; Shuai YF; Wu YP Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1553-6. PubMed ID: 18956639 [TBL] [Abstract][Full Text] [Related]
3. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Wu Y; Yakar S; Zhao L; Hennighausen L; LeRoith D Cancer Res; 2002 Feb; 62(4):1030-5. PubMed ID: 11861378 [TBL] [Abstract][Full Text] [Related]
4. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of insulin-like growth factor-1 (IGF-1) to angiogenesis of breast cancer in IGF-1-deficient mice]. Tang HB; Ren YP; Zhang J; Ma SH; Gao F; Wu YP Ai Zheng; 2007 Nov; 26(11):1215-20. PubMed ID: 17991321 [TBL] [Abstract][Full Text] [Related]
6. Age-dependent onset of liver-specific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice. Tang Z; Yu R; Lu Y; Parlow AF; Liu JL Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E288-95. PubMed ID: 15769793 [TBL] [Abstract][Full Text] [Related]
7. Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse. Yakar S; Pennisi P; Zhao H; Zhang Y; LeRoith D Novartis Found Symp; 2004; 262():3-9; discussion 9-18, 265-8. PubMed ID: 15562820 [TBL] [Abstract][Full Text] [Related]
8. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival. Shin A; Ren Z; Shu XO; Cai Q; Gao YT; Zheng W Breast Cancer Res Treat; 2007 Sep; 105(1):55-61. PubMed ID: 17066319 [TBL] [Abstract][Full Text] [Related]
9. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. Perera CN; Chin HG; Duru N; Camarillo IG J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880 [TBL] [Abstract][Full Text] [Related]
10. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer. Chong YM; Subramanian A; Sharma AK; Mokbel K Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785 [TBL] [Abstract][Full Text] [Related]
12. The expression and function of IGFBP-3 in normal and malignant breast tissue. McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377 [TBL] [Abstract][Full Text] [Related]
14. [The effect of 20(R)-ginsenoside Rg3 on the differential expression of cell signaling genes and other related genes in human lung adenocarcinoma cell line A549]. Chen MW; Yang L; Ni L; Guo X; Tian RZ; Wang XQ Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):37-40. PubMed ID: 15774190 [TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I inhibits growth regulatory responses engaged by estrogen and progesterone in the mouse mammary gland. Mathews L; Schneider SS Eur J Cancer Prev; 2008 Aug; 17(4):297-305. PubMed ID: 18562952 [TBL] [Abstract][Full Text] [Related]
17. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Wagner K; Hemminki K; Försti A Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888 [TBL] [Abstract][Full Text] [Related]
18. Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray. Sheen-Chen SM; Chou FF; Hsu W; Huang CC; Eng HL; Tang RP Anticancer Res; 2007; 27(5B):3541-4. PubMed ID: 17972515 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892 [TBL] [Abstract][Full Text] [Related]
20. [Changes in gene expression in the course of proliferative processes in the parathyroid gland]. Szende B; Arvai K; Peták I; Nagy K; Végsô G; Perner F Magy Onkol; 2006; 50(2):137-40. PubMed ID: 16888677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]